Latest news by search query "covid 19 test kits"

Related News

Flu and COVID-19 surveillance report published - gov.uk
gov.uk
38%
952
Flu and COVID-19 surveillance report published
.COVID-19 activity remained stable.SARS-CoV-2 positivity remained stable at 3.7% in week 11 compared to 3.7% in the previous week. This is based on a percentage of people who test positive among those with symptoms tested at sentinel “spotter” laboratories, reported through the Respiratory DataMart surveillance system.COVID-19 case rates and positivity in Pillar 1 decreased overall and within some age, ethnic groups, and regions in week 11.Through the SIREN healthcare cohort study, the SARS-CoV-2 positivity increased in week 11 compared to the previous week.COVID-19 hospitalisations increased slightly to 1.85 per 100,000 compared to 1.76 per 100,000 in the previous week.COVID-19 ICU admissions remained low and stable at 0.06 per 100,000 in week 11.The total number of confirmed COVID-19 acute respiratory incidents decreased compared to the previous week, with 5 incidents reported in England during week 11.The highest hospital admission rate is currently in the North East at 3.44 per 100,000.Those aged 85 years and over had the highest hospital admission rate, which increased to 21.45 per 100,000, with most of the remaining age groups remaining stable.Details of the Spring 2024 COVID-19 vaccination programme will be confirmed soon by NHS England, which will be offered to those who are aged 75 years and over, residents in a care home for older adults and individuals aged 6 months and over who are immunosuppressed.Influenza activity remained stable.Influenza positivity increased slightly to 5.9% in week 11 compared to 5.3% in the previous week.
Clinical platform trials for coronavirus (COVID-19) treatments - gov.uk - Britain
gov.uk
79%
989
Clinical platform trials for coronavirus (COVID-19) treatments
, the COVID-19 Antivirals and Therapeutics Taskforce closed on 31 March 2023.Find out more about on the National Institute for Health and Care Research (NIHR) website.Find out more about on the NHS website.Clinical trials are essential to finding new and improved methods of treating different diseases including coronavirus (COVID-19).Clinical trials allow us to understand whether new treatments:Phase 1 and 2 trials are early-stage trials involving small numbers of participants to ensure a treatment is safe to use and shows evidence of a benefit beyond the standard of care.Treatments that are found to be safe at this stage may then proceed to be tested in a phase 3 clinical trial.Phase 3 trials involve large numbers of patients and assess whether a treatment is effective enough to be used more widely in the NHS.The National Institute for Health and Care Research (NIHR) established a single UK-wide process to prioritise COVID-19 research as Urgent Public Health research early in the COVID-19 pandemic. The purpose was to:The COVID-19 Antivirals and Therapeutics Taskforce worked with NIHR and other partners to horizon scan and monitor national and international developments in COVID-19 antivirals and therapeutics.The Department of Health and Social Care (DHSC) is continuing to support a series of national clinical trial ‘platforms’ across all phases of human trials and in a range of patient cohorts.
Felicia Parrillo - Covid - End of free COVID-19 test kits in pharmacies for most Quebecers - globalnews.ca
globalnews.ca
56%
262
End of free COVID-19 test kits in pharmacies for most Quebecers
COVID-19 rapid tests for free at their local pharmacies as of Monday.Those who are considered to be at high risk of complications from the disease — including immunocompromised and pregnant people — will still be able to pick up test kits at no additional cost until April 2024.Seniors, full-time students under the age of 25 and children who benefit from free medication under the province’s drug insurance plan will also still have access to free COVID-19 tests, according to the Health Ministry.The ministry, which announced the move in late March, cited the improving pandemic situation in Quebec as the reason for scaling back the program.Quebec’s pharmacists association, the Association québécoise des pharmaciens propriétaires (AQPP), said those who do not meet the criteria for no-charge tests will still be able to buy kits in pharmacies.“Since the start of the program, Quebec pharmacies have distributed nearly 9,250,000 kits of self-administered tests,” AQPP president Benoit Morin said in a statement.In December 2021, the government announced that COVID-19 rapid tests would be made available to the general population through select pharmacies. People would have access to five free tests every 30 days.The Health Ministry says COVID-19 tests will continue to be distributed for free in schools and child-care centres.— with files from Global’s Felicia Parrillo and The Canadian Press
DMCA